- Home
- / Oncoceutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Oncoceutics financials data including stock price, CreditSafe score, balance sheet, and cash flow.
CreditSafe Score
?
Score changed on Jun 11, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | Q3, 2020 |
|---|---|
| Cash | 5.8M |
| Accounts Receivable | 543.3K |
| Prepaid Expenses | 24.1K |
| Current Assets | 8.4M |
| PP&E | 7.9K |
| Total Assets | 8.4M |
| Current Liabilities | 2.0M |
| Long-term Debt | 265.0K |
| Total Debt | 265.0K |
| Total Liabilities | 4.8M |
| Common Stock | 7.6K |
| Preferred Stock | 5.6K |
| Additional Paid-in Capital | 23.7M |
| Retained Earnings | (20.1M) |
| Total Equity | 3.6M |
| Debt to Equity Ratio | 0.1 |
| Debt to Assets Ratio | 0 |
| Financial Leverage | 2.3 |